NOS2 and Parkinson disease: Similarly, PTP1B inhibition dampens inflammation in zebrafish models of Parkinson’s disease by reducing the expression of IFN-ɣ-induced pro-inflammatory cytokines such as iNOS, COX2 and NF-κB while upregulating M2 markers in microglial cells, improving neuronal damage [68].